- Home
- ABP vs PDSB Comparison
ABP vs PDSB Comparison
Compare ABP & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABP
- PDSB
- Stock Information
- Founded
- ABP 2004
- PDSB 2005
- Country
- ABP United States
- PDSB United States
- Employees
- ABP N/A
- PDSB N/A
- Industry
- ABP Biotechnology: Pharmaceutical Preparations
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- ABP Health Care
- PDSB Health Care
- Exchange
- ABP Nasdaq
- PDSB Nasdaq
- Market Cap
- ABP 78.8M
- PDSB 84.2M
- IPO Year
- ABP N/A
- PDSB N/A
- Fundamental
- Price
- ABP $1.10
- PDSB $1.92
- Analyst Decision
- ABP
- PDSB Strong Buy
- Analyst Count
- ABP 0
- PDSB 3
- Target Price
- ABP N/A
- PDSB $14.00
- AVG Volume (30 Days)
- ABP 47.0K
- PDSB 391.7K
- Earning Date
- ABP 04-03-2025
- PDSB 11-14-2024
- Dividend Yield
- ABP N/A
- PDSB N/A
- EPS Growth
- ABP N/A
- PDSB N/A
- EPS
- ABP N/A
- PDSB N/A
- Revenue
- ABP $122,000.00
- PDSB N/A
- Revenue This Year
- ABP N/A
- PDSB N/A
- Revenue Next Year
- ABP N/A
- PDSB N/A
- P/E Ratio
- ABP N/A
- PDSB N/A
- Revenue Growth
- ABP N/A
- PDSB N/A
- 52 Week Low
- ABP $1.12
- PDSB $1.53
- 52 Week High
- ABP $13.00
- PDSB $6.68
- Technical
- Relative Strength Index (RSI)
- ABP N/A
- PDSB 37.63
- Support Level
- ABP N/A
- PDSB $1.78
- Resistance Level
- ABP N/A
- PDSB $2.05
- Average True Range (ATR)
- ABP 0.00
- PDSB 0.16
- MACD
- ABP 0.00
- PDSB 0.02
- Stochastic Oscillator
- ABP 0.00
- PDSB 27.94
About ABP Abpro Holdings Inc Common Stock
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.